Recent News

• 06.06.2025 - A Phase 3 Protocol to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Adults at High Risk of Severe RSV Disease
• 06.04.2025 - May Social Media Round-Up—Q1 Earning Results, Bladder Cancer Awareness Month, and More

Recent Filings

• 06.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.30.2025 - SD Specialized disclosure report
• 05.23.2025 - 144 Report of proposed sale of securities
• 05.20.2025 - CERT Certification by an exchange approving securities for listing
• 05.19.2025 - 8-A12B Registration of securities [Section 12(b)]
• 05.19.2025 - 8-K Current report
• 05.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 05.14.2025 - FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
• 05.13.2025 - 13F-HR Quarterly report filed by institutional managers, Holdings